Skip to main content

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Mecanismes de regulació transcripcional del gen que codifica per a la Kidney Androgen-regulated Protein (KAP) en relació a la seva especifitat de teixit i control hormonal

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2003FI 00132
Duration: 01/01/2003 - 31/12/2006

Generación d'animals transgènics i KNOCK-OUTS pel gen de la Kidney androgen-regulated protein (KAP). Aplicació d'aquests models per a l'estudi de la toxicitat renal per ciclosporina (CsA).

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 13000
Reference: PRED/IR-HUVH/05/2002
Duration: 01/01/2003 - 31/12/2006

Mecanismes de regulació transcripcional del gen SA i caracterització i funció de la proteïna en la matriu mitocondrial

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding:
Reference: PRED_IR_HUVH_2001_04
Duration: 01/01/2002 - 31/12/2004

Nefrotoxicitat aguda per CsA en pacients sotmesos a trasplantament. Bases moleculars i implicació del gen que codifica ara la Kidney androgen-regulated Protein

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Fundació La Marató de TV3
Funding: 114065.73
Reference: TV3/002230
Duration: 22/01/2001 - 21/01/2004

Related news

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

Researchers at the VHIR have carried out a study showing that the ClC-5 protein regulates collagen levels through the β-catenin pathway and lysosomal degradation.

The research will perform a functional analysis of phenotype-modifying genetic variants in patients affected by familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (HFHNC).

Related professionals

Albert Barberà LLuis

Albert Barberà LLuis

Director/a d'Àrea
External Strategy Directorate
Read more
Judit Amigó Farran

Judit Amigó Farran

Predoctoral researcher
Diabetes and Metabolism
Read more
Alba Rojano Toimil

Alba Rojano Toimil

Predoctoral researcher
Diabetes and Metabolism
Read more
Neus Mongay Ochoa

Neus Mongay Ochoa

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.